Cannabis Investing Canntab and Emblem Announce Positive Results on Testing: Proceeding to Clinical Trials
Cannabis Investing Emblem and Canntab to Commence Clinical Testing of 12-Hour Extended Release Cannabis Tablets
Cannabis Investing Emblem Signs Supply Agreement with Aphria to Purchase up to 175,000 kg Equivalents of Cannabis Products Over Five Years
Cannabis Investing UPDATE: Emblem Signs Five-Year Supply Agreement with Compass Cannabis Clinic for Starbuds Canada
